This study found that dynamic prediction models from the pre-CFTR modulator era can be effectively adapted to characterize ivacaftor responsiveness in people with CF while providing accurate, individualized predictions of precipitous drops in lung function that may provide an early signal for the onset of a pulmonary exacerbation. Here, CFTR is linked to cystic fibrosis.